kısım 1 temel kalp yetersizliği - Rasim Enar

164
KANITA DAYALI KALP YETERSİZLİĞİ KİTABI
12. Packer M, Bristow MR, Cohn JN, et al. The effect of carvedilol
on morbidity and mortality in patients with chronic
heart failure. N Engl J Med 1996;334:1349-55.
13. CIBIS II Investigational Committees. The Cardiac Insufficiency
Bisoprolol Study II (CIBIS II): a randomised trial.
Lancet 1999;353:9-13.
14. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol
CR/XL Randomised Intervention Trial in Congestive
Heart Failure (MERIT-HF). Lancet 1999;353:2001-7.
15. Francis GS, Benedict C, Johnston DE, et al. Comparison of
neuroendocrine activation in patients with left ventricular
dysfunction with and without congestive heart failure: a
substudy of the Studies of Left Ventricular Dysfunction
(SOLVD). Circulation 1990;82:1724-9.
16. Levine TB, Francis GS, Goldsmith SR, Simon AB, Cohn JN.
Activity of the sympathetic nervous system and renin-angiotensin
system assessed by plasma hormone levels and
their relation to hemodynamic abnormalities in congestive
heart failure. Am J Cardiol 1982;49:1659-66.
17. Schrıer RW. Abraham WT. Hormones and Hemodynamıcs
ın heart failure. NEJM 1999;341:577- 85
18. Fekler GM. Adams KF. Milo-Cotter O. O’Connor MC. Pathophysiology
of Acute heart failure-is it all about fluid accumulatıon.
Am Heart J 2008;155:9-18
19. Cas LD. Bristow MR. Pathophysiology of acute heart failure-
it is a lot about fluid accumulatıon. Am Heart J 2008;155:
1-5
20. Thierry HL, Claudia S. Vasopressin dysregulation: Hyponatremia,
fluid retention and congestive heart failure. International
Journal of Cardiology 120 (2007) 1–9